Skip to content

The combination of simethicone, NAC and lidocaine in ice popsicle compared with lidocaine ice popsicle with simethicone, NAC solution in patients undergoing unsedated esophagogastroduodenoscopy

The combination of simethicone, NAC and lidocaine in ice popsicle compared with lidocaine ice popsicle with simethicone, NAC solution in patients undergoing unsedated esophagogastroduodenoscopy

Status
Unknown
Phases
Phase 1Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20221113002
Enrollment
374
Registered
2022-11-13
Start date
2022-12-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Upper GI cancer , cancer screening and work-up for symptomatic patients in patients with dysphagia, dyspepsia, reflux, abdominal pain, or anemia Simethicone , N-acetylcysteine , lidocaine , ice popsicle, topical pharyngeal anesthesia unsedated esophagogastroduodenoscopy, unsedated upper gastrointestinal endoscopy

Interventions

-6 ml viscous lidocaine solution ( 20 mg/ml ) with pre-medication agents (Simethicone 80 mg + NAC 600 mg) premixed in ice popsicle formula -Formed solution of viscous lidocaine , simethicone 80 mg an
Experimental Drug,Experimental Drug
Lidocaine with pre-medication agents in ice popsicle formula group ,Lidocaine ice popsicle formula Then applied pre-medication solution via EGD port group

Sponsors

Faculty of medicine ,Thammasat university hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to No maximum

Inclusion criteria

Inclusion criteria: A minimum age of 20 years Eligible for unsedated diagnostic EGD via the oral route by pharyngeal anesthesia at Thammasat University Hospital Upper GI cancer , cancer screening and work-up for symptomatic patients in patients with dysphagia, dyspepsia, reflux, abdominal pain, or anemia Patients who did not have allergy and contraindications to pre-medications with a compound solution ( simethicone , N-acetylcysteine and lidocaine ) All patients were fully informed of the purpose of this study and consent was obtained from all participants before this study

Exclusion criteria

Exclusion criteria: Previous upper gastrointestinal surgery Severe dysphagia ( Dysphagia grade V,VI ) Clinical obstruction Corrosive ingestion Upper gastrointestinal bleeding Pregnancy Contraindication for EGD Allergy to pre-medications Emergency cases and unstable vital signs

Design outcomes

Primary

MeasureTime frame
Visualisation After intervention was done Total visibility score

Secondary

MeasureTime frame
The amount of water used to allow suitable visualization of gastric mucosa After intervention Volume of water,Time to complete the EGD After intervention Minutes,Safety outcome During intervention Oxygen saturation , Heart rate , Blood pressure ,Endoscopist satisfication After intervention Satisfaction score,Patient satisfication After intervention Satisfaction score

Countries

Thailand

Contacts

Public ContactPailin Intarasangkhanawin

Thammasat university hospital

ingpailinin@gmail.com0840547060

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026